产品封面图

DMS 153

收藏
  • 询价
  • 2026年01月09日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      大量

    • 年限

      44 years

    • 相关疾病

      小细胞肺癌

    • ATCC Number

      CRL-2064™

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 器官来源

    • 运输方式

      冻存运输

    • 生长状态

      单层、贴壁

    Designations: DMS 153
    Depositors:  OS Pettengill, G Sorenson
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: monolayer of adherent clusters
    Organism: Homo sapiens
    Morphology:
    Source: Organ: lung
    Disease: carcinoma; small cell lung cancer
    Derived from metastatic site: liver
    Cellular Products: adrenocorticotropin (adrenocorticotropic hormone, ACTH); bombesin; calcitonin; calcitonin gene related peptide (CGRP); oxytocin - neurophysin (OT-NP); 17 beta estradiol
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Restrictions: Note: These cells are distributed subject to the following: 1.) This cell line or its products must not be distributed to third parties. Commercial interests are the exclusive property of Dartmouth College. 2.) Any proposed commercial use of these cells must first be negotiated with Office of Technology Transfer, Dartmouth College, Hanover, NH, 03755. Tel: (603) 646-3675. 3.) In all papers reporting any use of these cells, or derived products, a direct reference will be made to the original publications.
    Receptors: bombesin; epidermal growth factor (EGF); complement (CR3)
    Tumorigenic: Yes
    Antigen Expression: Leu 7 +; My23 +; CD11b +
    Age: 44 years
    Gender: male
    Ethnicity: Caucasian
    Comments: The line was established from cells from liver tissue taken at autopsy of a patient with small cell carcinoma of the lung.
    The patient had received prior therapy with cytoxan and methotrexate.
    The cells express HLA class I and class II antigens.
    Propagation: ATCC complete growth medium: Waymouth's MB 752/1 medium, 90%; fetal bovine serum, 10%
    Subculturing: Medium Renewal: Twice per week
    Remove the spent medium, add fresh 0.25% trypsin, 0.03% EDTA solution, rinse and remove trypsin.
    Add fresh trypsin solution (1 to 2 ml) and let the culture sit at room temperature (or 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks.
    Set up flasks at about 9 X 10 exp6 cells per 75 sq. cm. flask.
    Preservation: Culture medium, 95%; DMSO, 5%
    References: 22793: Pettengill OS, et al. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45: 906-918, 1980. PubMed: 6266631

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • DMS Chemical Footprinting of RNA

      10X CE 9 mL H2O DMS Solution: 15 uL 100% ETOH 3 uL DMS Quench Solution: 1.4 mL 2-beta-mercaptoethanol 0.5 mL 3 M Sodium Acetate (Ambion

    • PCR技术应用八:DMS/BMD基因诊断

            DMD(Duchenne Muscular Dystrophy)和BMD(Becker Muscular Dystrophy)是一种常见的X连锁隐性遗传病,主要发生于男性,其发病率为1/3500活产男婴,其发生的原因是Dystrophin(抗肌萎缩蛋)其固缺陷所致. 一、DMD/BMD的临床表现   在临床上DMD较BMD常见,发病早,症状重,正常于2-3岁即出现骨骼肌无力的表现,一般从骨盒带肌肉无力开始而出现一系列的特殊症状:走路困难呈鸭步

    • PCR在DMS/BMD基因诊断中的应用

      PCR 在DMS/BMD基因诊断中的应用   DMD(Duchenne Muscular Dystrophy)和BMD(Becker Muscular Dystrophy)是一种常见的X连锁隐性遗传病,主要发生于男性,其发病率为1/3500活产男婴,其发生的原因是Dystrophin(抗肌萎缩蛋)其固缺陷所致. 一、DMD/BMD的临床表现   在临床上DMD较BMD常见,发病早,症状重,正常于2-3岁即出现骨骼肌无力的表现,一般从骨盒带肌肉无力开始而出现一系列的特殊症状:走路困难呈

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥4600
    博辉生物科技(广州)有限公司
    2025年09月24日询价
    ¥680
    上海联迈生物工程有限公司
    2025年11月13日询价
    ¥600
    上海信裕生物科技有限公司
    2025年07月14日询价
    ¥5000
    上海酶研生物科技有限公司
    2025年07月10日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    DMS 153
    询价